Literature DB >> 21705366

Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila.

Yasmina Talmat-Amar1, Yoan Arribat, Christelle Redt-Clouet, Sébastien Feuillette, Anne-Laure Bougé, Magalie Lecourtois, Marie-Laure Parmentier.   

Abstract

The microtubule-associated protein Tau is found in large amount in axons of neurons and is involved in human neurodegenerative diseases called tauopathies, which include Alzheimer's disease. In these diseases, the Tau protein is abnormally hyperphosphorylated and one therapeutic strategy currently under consideration consists in inhibiting Tau phosphorylation. However, the consequences of an excess of hypophosphorylated Tau onto neuronal physiology have not been investigated in vivo. Here we studied how important is Tau phosphorylation for axonal transport and neurohormone release in vivo, using the Drosophila model. Surprisingly, our results demonstrate a stronger toxicity of hypophosphorylated Tau for neuronal function, when compared with normal or pseudophosphorylated Tau. This reveals a potential limit of the current therapeutic strategy aimed at inhibiting Tau phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705366     DOI: 10.1093/hmg/ddr290

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  19 in total

1.  The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicity in Vivo.

Authors:  Engie Prifti; Eleni N Tsakiri; Ergina Vourkou; George Stamatakis; Martina Samiotaki; Katerina Papanikolopoulou
Journal:  J Neurosci       Date:  2020-12-17       Impact factor: 6.167

2.  T-complex protein 1-ring complex enhances retrograde axonal transport by modulating tau phosphorylation.

Authors:  Xu-Qiao Chen; Fang Fang; Jazmin B Florio; Edward Rockenstein; Eliezer Masliah; William C Mobley; Robert A Rissman; Chengbiao Wu
Journal:  Traffic       Date:  2018-09-12       Impact factor: 6.215

3.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Jose Sarmiento; Juan Troncoso; George R Jackson; Rakez Kayed
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

4.  The microtubule-associated protein Tau suppresses the axonal distribution of PDF neuropeptide and mitochondria in circadian clock neurons.

Authors:  Melanie Y Zhang; Bridget C Lear; Ravi Allada
Journal:  Hum Mol Genet       Date:  2022-03-31       Impact factor: 6.150

Review 5.  Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity.

Authors:  Yunpeng Huang; Zhihao Wu; Bing Zhou
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

6.  Tau Phosphorylation by GSK3 in Different Conditions.

Authors:  Jesús Avila; Gonzalo León-Espinosa; Esther García; Vega García-Escudero; Félix Hernández; Javier Defelipe
Journal:  Int J Alzheimers Dis       Date:  2012-05-17

7.  Recessive Mutations in RTN4IP1 Cause Isolated and Syndromic Optic Neuropathies.

Authors:  Claire Angebault; Pierre-Olivier Guichet; Yasmina Talmat-Amar; Majida Charif; Sylvie Gerber; Lucas Fares-Taie; Naig Gueguen; François Halloy; David Moore; Patrizia Amati-Bonneau; Gael Manes; Maxime Hebrard; Béatrice Bocquet; Mélanie Quiles; Camille Piro-Mégy; Marisa Teigell; Cécile Delettre; Mireille Rossel; Isabelle Meunier; Markus Preising; Birgit Lorenz; Valerio Carelli; Patrick F Chinnery; Patrick Yu-Wai-Man; Josseline Kaplan; Agathe Roubertie; Abdelhamid Barakat; Dominique Bonneau; Pascal Reynier; Jean-Michel Rozet; Pascale Bomont; Christian P Hamel; Guy Lenaers
Journal:  Am J Hum Genet       Date:  2015-10-22       Impact factor: 11.025

8.  Identification of cis-acting determinants mediating the unconventional secretion of tau.

Authors:  Taxiarchis Katsinelos; William A McEwan; Thomas R Jahn; Walter Nickel
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

9.  Loss of vesicular dopamine release precedes tauopathy in degenerative dopaminergic neurons in a Drosophila model expressing human tau.

Authors:  Ting-Han Wu; Yu-Ning Lu; Chia-Lung Chuang; Chia-Lin Wu; Ann-Shyn Chiang; David E Krantz; Hui-Yun Chang
Journal:  Acta Neuropathol       Date:  2013-03-15       Impact factor: 17.088

10.  A huntingtin peptide inhibits polyQ-huntingtin associated defects.

Authors:  Yoan Arribat; Nathalie Bonneaud; Yasmina Talmat-Amar; Sophie Layalle; Marie-Laure Parmentier; Florence Maschat
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.